ALPINE, N.J., Nov. 9, 2011 /PRNewswire/ — ProTron
Technologies announces a new approach to early detection of aneurysms in
vascular systems through the patented Stethotron® Cerebral Stethoscope.
In the USA
alone, six million people have a brain aneurysm. In 50% of ruptured aneurysms,
patients in the age group of 35-60 die within minutes.
One of the major factors leading to aneurysm is vascular
atherosclerosis. Without invasive procedures, doctors, using the Stethotron
Cerebral Stethoscope, can now quickly and easily detect the atherosclerotic
changes leading to cerebral aneurysms before acute symptoms appear, when it may
be too late and is costly to treat.
Please visit us on the web at http://www.stethotron.com
to sample audible detection with the Stethotron.
About the Stethotron
Unlike ultrasound, the Stethotron is non-invasive and avoids listening to
undesirable wavelengths. Using our patented filtration, doctors may detect the
audible, vascular turbulence at 250-1000 Hz that reveals pathology. Eliminating
the cost of ultrasound, and in only minutes, the Stethotron provides a
revolution in doctor/patient care.